| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 5.05 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
"The malaria drug pipeline has been highly affected by the fastdeveloping
rate of Plasmodium resistance to the currently available
drugs. There are two promising and complementary approaches being
explored to mitigate drug resistance. One is focused on the drugs, and
includes the development of drugs exploiting novel targets and the
combination of drug partners presenting the same pharmacokinetic
properties but distinct modes of action. The other approach is to explore
the life cycle of the parasite and target the hepatic stage of the
Plasmodium life cycle.(...)"
Descrição
Palavras-chave
Plasmodium liver
